Regis Corp Appoints New CEO, Interim CFO
Ticker: RGS · Form: 8-K · Filed: Jan 24, 2025 · CIK: 716643
| Field | Detail |
|---|---|
| Company | Regis Corp (RGS) |
| Form Type | 8-K |
| Filed Date | Jan 24, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.05 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-appointment, management-transition
Related Tickers: RGS
TL;DR
Regis Corp just hired a new CEO, Matthew Doctor, and an interim CFO. Big changes coming?
AI Summary
On January 21, 2025, Regis Corporation announced changes in its executive leadership. The company appointed Matthew Doctor as Chief Executive Officer and a member of the Board of Directors, effective immediately. Additionally, Hugh E. Sawyer was appointed as Interim Chief Financial Officer, succeeding Andrew J. D. Weiland.
Why It Matters
The appointment of a new CEO and interim CFO signals a potential shift in strategic direction for Regis Corporation, which could impact its future performance and stock value.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty and potential strategic shifts, which carry inherent risks for the company's future operations and financial performance.
Key Players & Entities
- Regis Corporation (company) — Registrant
- Matthew Doctor (person) — Appointed Chief Executive Officer and Board Member
- Andrew J. D. Weiland (person) — Former Interim Chief Financial Officer
- Hugh E. Sawyer (person) — Appointed Interim Chief Financial Officer
- January 21, 2025 (date) — Effective date of appointments
FAQ
Who has been appointed as the new Chief Executive Officer of Regis Corporation?
Matthew Doctor has been appointed as the new Chief Executive Officer of Regis Corporation.
When were the leadership changes effective?
The leadership changes were effective as of January 21, 2025.
Who succeeded Andrew J. D. Weiland as Interim Chief Financial Officer?
Hugh E. Sawyer was appointed as the Interim Chief Financial Officer, succeeding Andrew J. D. Weiland.
What other role did Matthew Doctor assume?
In addition to CEO, Matthew Doctor was also appointed as a member of the Board of Directors.
What is the principal executive office address for Regis Corporation?
The principal executive offices are located at 3701 Wayzata Boulevard, Suite 500, Minneapolis, MN 55416.
Filing Stats: 499 words · 2 min read · ~2 pages · Grade level 14.3 · Accepted 2025-01-24 16:21:14
Key Financial Figures
- $0.05 — ange on which registered Common Stock, $0.05 par value RGS The Nasdaq Global Market
Filing Documents
- rgs-20250121.htm (8-K) — 27KB
- 0000716643-25-000005.txt ( ) — 148KB
- rgs-20250121.xsd (EX-101.SCH) — 2KB
- rgs-20250121_lab.xml (EX-101.LAB) — 21KB
- rgs-20250121_pre.xml (EX-101.PRE) — 12KB
- rgs-20250121_htm.xml (XML) — 3KB
From the Filing
rgs-20250121 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2025 REGIS CORP ORATION (Exact name of registrant as specified in charter) Minnesota 1-12725 41-0749934 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3701 Wayzata Boulevard Minneapolis , MN 55416 (Address of principal executive offices and zip code) ( 952 ) 947-7777 (Registrant's telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Common Stock, $0.05 par value RGS The Nasdaq Global Market Rights to Purchase Series A Junior Participating Preferred Stock, $0.05 par value RGS The Nasdaq Global Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Regis Corporation Current Report on Form 8-K ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATION ARRANGEMENTS OF CERTAIN OFFICERS. On January 24, 2025, Regis Corporation (the "Company") announced that the position held by John Davi, the Company's Executive Vice President and Chief Digital Officer, will be eliminated effective January 31, 2025, entitling him to severance benefits under the Company's Amended and Restated Senior Executive Severance Policy, provided that he complies with the conditions set forth therein. Provided Mr. Davi signs a transition and separation agreement and complies with the obligations set forth therein and signs and does not rescind a release, he will continue as an employee in a non-officer role through March 31, 2025, at his current compensation, to facilitate the transition of his responsibilities. SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REGIS CORPORATION Dated: January 24, 2025 By: /s/ Kersten D. Zupfer Kersten D. Zupfer Executive Vice President and Chief Financial Officer